We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

222 hedge funds and large institutions have $3.53B invested in SpringWorks Therapeutics in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

839% more call options, than puts

Call options by funds: $465M | Put options by funds: $49.6M

100% more funds holding in top 10

Funds holding in top 10: 9 → 18 (+9)

20% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 69

7% more capital invested

Capital invested by funds: $3.29B → $3.53B (+$235M)

0.13% more ownership

Funds ownership: 99.46% → 99.59% (+0.13%)

27% less funds holding

Funds holding: 306 → 222 (-84)

61% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 132

Holders
222
Holders Change
-84
Holders Change %
-27.45%
% of All Funds
2.92%
Holding in Top 10
18
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+100%
% of All Funds
0.24%
New
51
Increased
83
Reduced
69
Closed
132
Calls
$465M
Puts
$49.6M
Net Calls
+$416M
Net Calls Change
+$248M

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$183M
2
Fidelity International
Fidelity International
Bermuda
+$134M
3
TAL
TIG Advisors LLC
New York
+$105M
4
BCM
Beryl Capital Management
California
+$94.2M
5
MF
Magnetar Financial
Illinois
+$91.3M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$498M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$112M
3
PCH
Polar Capital Holdings
United Kingdom
-$77.2M
4
WP
Woodline Partners
California
-$76M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$73.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
251
Caption Management
Oklahoma
– -$5.2M -116,994 Closed
Swiss National Bank
252
Swiss National Bank
Switzerland
– -$5.09M -115,300 Closed
TD Asset Management
253
TD Asset Management
Ontario, Canada
– -$5.05M -114,378 Closed
Envestnet Asset Management
254
Envestnet Asset Management
Illinois
– -$5.04M -114,274 Closed
CS
255
Candriam SCA
Luxembourg
– -$4.27M -96,778 Closed
OCM
256
Ovata Capital Management
Hong Kong
– -$4.22M -95,664 Closed
RA
257
RFG Advisory
Alabama
– -$3.93M -88,995 Closed
BGIM
258
Boussard & Gavaudan Investment Management
United Kingdom
– -$3.87M -86,500 Closed
SC
259
Shay Capital
New York
– -$3.8M -86,200 Closed
Assenagon Asset Management
260
Assenagon Asset Management
Luxembourg
– -$3.51M -79,640 Closed
EI
261
EAM Investors
California
– -$3.17M -71,941 Closed
HS
262
HighVista Strategies
Massachusetts
– -$3.03M -68,758 Closed
DP
263
Diadema Partners
New Jersey
– -$2.65M -60,000 Closed
EDRH
264
Edmond de Rothschild Holding
Switzerland
– -$2.65M -60,000 Closed
MCM
265
M28 Capital Management
Connecticut
– -$2.44M -55,200 Closed
SCM
266
Superstring Capital Management
New York
– -$2.39M -54,216 Closed
AI
267
Allostery Investments
Connecticut
– -$2.32M -52,500 Closed
SFM
268
Sphera Funds Management
Israel
– -$2.3M -52,009 Closed
AAM
269
AMI Asset Management
California
– -$2.23M -50,640 Closed
LCAM
270
Long Corridor Asset Management
Hong Kong
– -$2.21M -50,000 Closed
PIM
271
Platinum Investment Management
Australia
– -$2.06M -46,671 Closed
Simplex Trading
272
Simplex Trading
Illinois
– -$2.07M -46,435 Closed
Macquarie Group
273
Macquarie Group
Australia
– -$2.05M -46,405 Closed
GL
274
Governors Lane
New York
– -$2M -45,400 Closed
Capital International Investors
275
Capital International Investors
California
– -$1.99M -45,143 Closed
9 10
11
12 13

SWTX Hedge Fund Activity: Q2 2025 in Review

222 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q2 2025, worth a combined $3.53B — up 7.1% from $3.29B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of SWTX and 51 opened new positions — a net loss of 81 holders — while 69 trimmed existing stakes and 83 added.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $183M. The largest seller was Fidelity Investments, cutting an estimated $498M.

  • 222 institutional investors held SpringWorks Therapeutics (SWTX) as of Q2 2025, down from 306 in Q1 2025.
  • Funds reported $3.53B of SpringWorks Therapeutics stock for Q2 2025, up 7.1% quarter-over-quarter.
  • 51 funds opened new SpringWorks Therapeutics positions in Q2 2025 and 132 closed out, a net change of -81 holders.
  • The largest SpringWorks Therapeutics buyer in Q2 2025 was Glazer Capital LLC, an estimated $183M added.
  • The largest SpringWorks Therapeutics seller in Q2 2025 was Fidelity Investments, an estimated $498M sold.

Based on aggregated 13F filings for Q2 2025.